TransIT®-BrCa transfection reagent offers superior DNA transfection of breast cancer cell types.

• Broad spectrum DNA delivery
• Formulated for low cellular toxicity
• Superior transfection efficiency

TransIT®-BrCa Transfection Reagent is the first dedicated breast cancer cell line specific reagent available to researchers. While it delivers efficiently to many breast cancer cell types, it also maintains low cellular toxicity resulting in reduced experimental biases.